Invesco Ltd. Codexis, Inc. Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Codexis, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 96,078 shares of CDXS stock, worth $263,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,078
Previous 67,447
42.45%
Holding current value
$263,253
Previous $181,000
29.28%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding CDXS
# of Institutions
129Shares Held
69MCall Options Held
25.8KPut Options Held
20K-
Opaleye Management Inc. Boston, MA12.6MShares$34.5 Million7.35% of portfolio
-
Casdin Capital, LLC New York, NY7.2MShares$19.7 Million2.46% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.59MShares$12.6 Million0.0% of portfolio
-
Abrdn PLC4.2MShares$11.5 Million0.02% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $179M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...